You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY23 is not expected to be complete until September, 2024.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Gene Expression and Diagnosis of Diabetes

    SBC: ARTHROCHIP, LLC            Topic: N/A

    DESCRIPTION (provided by applicant): Autoimmune diseases are difficult to diagnose, as the symptoms can be nonspecific. A single test that could readily distinguish between an autoimmune and non-autoimmune disorder would allow physicians to focus efforts on the specific disease that affects the patient. This is critical for diabetes mellitus (DM), which has two subsets, Type I and Type II. The sub ...

    STTR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  2. Automated Test of Word Recognition- Phase II

    SBC: AUDIOLOGY, INC            Topic: N/A

    DESCRIPTION (provided by applicant): Over 5 million word recognition tests are administered annually by audiologists in the United States with an associated cost of more than $100 million. These tests are currently performed manually by highly trained audiologists. This application describes the Phase II development of automated clinical speech recognition tests using clinical test recordings and ...

    STTR Phase II 2005 Department of Health and Human ServicesNational Institutes of Health
  3. Audiometric Earphone- Phase 1

    SBC: AUDIOLOGY, INC            Topic: N/A

    DESCRIPTION (provided by applicant): This project seeks to develop an earphone for diagnostic audiometry with features that will significantly increase the efficiency and decrease the cost of routine hearing testing. The most-often used earphones emply a supra-aural design that has several undesirable characteristics, including 1) an "occlusion effect", an artificial increase in sensitivity to bon ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  4. High Purity Amphotericin B: A Safer Antimycotic in AIDS

    SBC: CUMBERLAND PHARMACEUTICALS, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): Cumberland Pharmaceuticals and the University of Mississippi Mycotic Research Centers' long-term goal will be to improve anti-fungal pharmacotherapy particularly for patients with human immunodeficiency infections (HIV). We are jointly developing a high purity amphotericin B (AmB HP) product for intravenous administration. The nominal purity of AmB HP is 95%; ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  5. New anti-complement therapy to reduce reperfusion injury

    SBC: ENDOPROTECH, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The purpose of this proposal is to provide proof-of-concept that a novel therapy that prevents complement activation could be effective in reducing ischemia reperfusion injury (IRI) in transplanted organs. Complement activation after IRI in transplanted organs is a well-known phenomenon that may be responsible for delayed graft function and the hastening of ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  6. Internet Savvy Caregiver: Dementia Training and Planner

    SBC: HEALTHCARE INTERACTIVE, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The overall goal of the Internet-Based Savvy Caregiver (IBSC) program is to develop and bring to market an Internet-based psycho-educational program designed to provide persons caring for relatives who have dementing disorders the knowledge, skills, and outlook they need to undertake and succeed in the caregiving role they have assumed. The IBSC program is comp ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  7. Rapid Bacterial Detection in Platelet Concentrates

    SBC: Medical Innovations International, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): A rapid detection system can be readily developed to prevent bacterial contamination in platelet concentrates that are intended for transfusion. Bacteria contamination of platelet concentrates intended for transfusion, represents the most frequent transfusion-associated infectious risk. Bacterial contamination levels as low as 102 to 103 CFU/ml have been ass ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  8. Rapid Detection of Aspirin Resistance in Human Subjects

    SBC: Medical Innovations International, Inc.            Topic: N/A

    DESCRIPTION (provided by applicant): The number of patients treated with antiplatelet agents increases annually. It is reported that over 20 million people in the U.S. alone take aspirin daily to induce some level of platelets inhibition. Clinical data shows that not all patients receive the full benefits of aspirin, and that a large patient to patient variability exists in aspirin induced platele ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  9. Enhancement of the Baculovirus Expression Vector System

    SBC: PARATECHS CORP            Topic: N/A

    DESCRIPTION (provided by applicant): The baculovirus expression vector system (BEVS) is one of the most powerful and versatile eukaryotic expression systems. The BEVS is being used to produce antigens for vaccine development, to manufacture human therapeutics, to develop faster acting biological insecticides and as a protein expression system for a multitude of research project. However, a limita ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
  10. Realistic Phantom Series for OLINDA/EXM Version 2

    SBC: RADAR, INC.            Topic: N/A

    DESCRIPTION (provided by applicant): The OLINDA/EXM code, which replaces the popular MIRDOSE code for calculating dose estimates in nuclear medicine applications, was given an exemption by the FDA on June 15, 2004 to be distributed as a medical device. The code will have a 3 year lifetime, and may be considered for re-release in June of 2007. The current code contains the traditional phantom typ ...

    STTR Phase I 2005 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government